Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Cash from Financing Activities (2016 - 2025)

Intellia Therapeutics (NTLA) has disclosed Cash from Financing Activities for 11 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 14.67% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $131.5 million through Dec 2025, down 29.21% year-over-year, with the annual reading at $131.5 million for FY2025, 29.21% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $2.0 million at Intellia Therapeutics, down from $114.9 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $668.7 million in Q3 2021, with the low at $2.0 million in Q4 2025.
  • Average Cash from Financing Activities over 5 years is $93.0 million, with a median of $24.0 million recorded in 2022.
  • Peak annual rise in Cash from Financing Activities hit 111906.7% in 2021, while the deepest fall reached 99.03% in 2021.
  • Over 5 years, Cash from Financing Activities stood at $2.3 million in 2021, then skyrocketed by 22082.59% to $505.8 million in 2022, then tumbled by 78.95% to $106.5 million in 2023, then tumbled by 97.82% to $2.3 million in 2024, then dropped by 14.67% to $2.0 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $2.0 million, $114.9 million, and $14.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.